Business Case

Curing Hepatitis C Could Yield Huge Economic Benefit

May 18, 2015

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3